Orbimed Advisors - CHEMOMAB THERAPEUTICS LTD ownership

CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 11 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CHEMOMAB THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$2,005,940
-31.9%
2,241,2740.0%0.04%
-18.9%
Q2 2023$2,947,275
-17.3%
2,241,2740.0%0.05%
-24.3%
Q1 2023$3,563,626
-56.8%
2,241,274
-13.1%
0.07%
-55.7%
Q4 2022$8,250,157
+28.5%
2,578,1740.0%0.16%
+32.8%
Q3 2022$6,420,000
-32.7%
2,578,1740.0%0.12%
-31.2%
Q2 2022$9,539,000
-22.9%
2,578,1740.0%0.17%
-13.9%
Q1 2022$12,375,000
-30.4%
2,578,1740.0%0.20%
-12.2%
Q4 2021$17,789,000
-37.7%
2,578,1740.0%0.23%
-27.1%
Q3 2021$28,566,000
-41.7%
2,578,1740.0%0.31%
-36.7%
Q2 2021$49,037,000
-33.8%
2,578,1740.0%0.50%
-28.3%
Q1 2021$74,019,0002,578,1740.69%
Other shareholders
CHEMOMAB THERAPEUTICS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Orbimed Advisors 2,241,274$2,005,9400.04%
Ikarian Capital, LLC 213,392$190,9860.02%
BOOTHBAY FUND MANAGEMENT, LLC 26,529$23,7430.00%
KESTRA PRIVATE WEALTH SERVICES, LLC 31,241$27,9610.00%
Qube Research & Technologies Ltd 44$390.00%
Moser Wealth Advisors, LLC 500$4480.00%
Newbridge Financial Services Group, Inc. 1,100$9850.00%
UBS Group AG 141$1260.00%
RHUMBLINE ADVISERS 2,843$2,5420.00%
OSAIC HOLDINGS, INC. 1,775$1,5870.00%
View complete list of CHEMOMAB THERAPEUTICS LTD shareholders